Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DNLI

Denali Therapeutics Inc.

CIK 0001714899 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$24.92
↓ 0.03 (-0.12%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals, Options

Key stats

Market Cap
$3.98B
P/E Ratio
-7.79
EPS
-2.97
Dividend Yield
Not covered
52W Position
84%
Beta
1.43

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
4.77
P/S
Not covered
EV/Revenue
Not covered
ROE
-61.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 84%
$12.58$27.30

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$512.54M
Total Assets
$1.14B
Free Cash Flow
-$422.10M

Recent news